touchLearning Activities
Dr Dariusz Hareza reflects on ESCMID Global 2025, highlighting its international scope, informal collaboration, and key themes in antimicrobial resistance. He discusses impactful sessions on global surveillance, Kazakhstan’s primary care initiatives, and novel approaches like CRISPR and AI, all pointing toward an innovative and integrated future in infectious diseases.
The US Food and Drug Administration (FDA) has approved the first virus-like particle (VLP) chikungunya vaccine PXVX0317 (VIMKUNYA™), for individuals aged 12 years and older, with Bavarian Nordic recently announcing its commercial launch.1,2 This approval addresses a critical unmet need for ...
Dr Simon Feys discusses his award-winning research on viral-associated pulmonary aspergillosis (VAPA) in critically ill patients, highlighting key insights into its pathophysiology, diagnostic challenges, and treatment gaps. His work combines clinical expertise with multi-omics analysis to improve understanding, detection, and management of this often-overlooked but potentially deadly fungal superinfection.
Dr Simon Feys discusses his journey into intensive care medicine, driven by the complexity and impact of treating critically ill patients. He highlights the central role of infections in ICU, the importance of broad medical knowledge, and how clinical experience and research together shape his approach to patient care and innovation.
Dr. Jon Salmanton-García discusses unmet needs in preventing and treating respiratory infections in haematology patients, highlighting real-world data insights and the urgent need for targeted vaccines and antivirals.
Jon Salmanton-García discusses the challenges of diagnosing and treating invasive fungal infections in low- and middle-income countries, shares insights from studies in Peru and Honduras, and highlights key research and overlooked findings from ESCMID Global 2025.
For more than 40 years, Rebecca Denison has lived with HIV and advocated for women affected by the virus. A longtime activist and founder of WORLD, she has witnessed the epidemic’s evolution. In this interview, she reflects on scientific progress, ongoing challenges, and why the fight against HIV is far from over.
Q&A with ESCMID Young Investigator 2025 Dr Xin Hui Chan: touchINFECTIOUS DISEASES Future Leader 2025
Dr Xin Hui Chan’s research focuses on developing equitable therapies for high-threat infectious diseases. She combines clinical trials, evidence synthesis, and modelling to address neglected infections and improve global health outcomes.
Dr Tony Bai, ESCMID Global 2025 Young Investigator Award winner, discusses his research on bacterial infections, antibiotic regimens, and his journey balancing clinical work, research, and family life.
Skye Opsteen is a first-generation MD/PhD trainee in the Medical Scientist Training Program at the University of Alabama at Birmingham, Birmingham, AL, USA. Under the mentorship of Dr Nathan Erdmann, her PhD research explores the impact of chronic HIV ...
“An HIV vaccine wouldn’t just save lives; it would transform entire communities” Despite decades of research and advances in HIV treatment, an effective vaccine is still in development. The disease's ability to mutate, evade the immune system and persist ...
Health authorities in the Democratic Republic of the Congo (DRC) are investigating a cluster of unexplained deaths in Ekoto Health Area, Basankusu Health Zone, Equateur Province. The initial report on 9 February 2025 documented 24 deaths in a single village, prompting an investigation ...
"Europe remains committed to the global fight to end polio once and for all" Polio may be a distant memory for many in Europe, but the virus is far from gone. New data reveal that vaccine-derived poliovirus type 2 (VDPV2) was ...
Dr Amesika Nyaku and the touchINFECTIOUS DISEASES team are thrilled to welcome a new editorial board member, Dr Jon Salmanton-García (University of Cologne, Germany), specializing in infectious diseases in immunocompromised patients, with a particular focus on respiratory viral infections ...
Calling All Healthcare Teams… Friday 28th February is Rare Disease Day Medics for Rare Disease, a UK registered charity, is asking healthcare professionals and healthcare students from UK and beyond, to join forces, to help drive rare disease awareness ...
The Conference on Retroviruses and Opportunistic Infections (CROI) is the leading global meeting for HIV research, bringing together over 4,000 experts from around the world. It serves as a platform for researchers to translate laboratory and clinical discoveries into meaningful advancements ...
The American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) has introduced a new groundbreaking set of guidelines to enhance infection prevention in regional anesthesia and interventional pain medicine procedures. Developed over four years, these recommendations address infection ...
Medics4RareDiseases is evolving. We are excited to announce a refresh of our strategy, a relaunch of our branding and even a new name! The charity has grown beyond our highest expectations over the last five years. With this ...
touchINFECTIOUS DISEASES
Register Now!
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
- Save your progress for video
- Keep track of your CME credits
- Add personalised learning notes
- Receive updates from course leaders and faculty
- Be the first to hear about new and exciting interactive learning opportunities
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
